StoneX Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-682
| Closed | -$331K | – | 1018 |
|
|
2025
Q1 | $331K | Buy |
682
+12
| +2% | +$5.82K | 0.02% | 595 |
|
|
2024
Q4 | $270K | Buy |
670
+14
| +2% | +$5.64K | 0.01% | 641 |
|
|
2024
Q3 | $305K | Sell |
656
-192
| -23% | -$89.3K | 0.14% | 212 |
|
|
2024
Q2 | $397K | Sell |
848
-30
| -3% | -$14.1K | 0.19% | 148 |
|
|
2024
Q1 | $367K | Buy |
878
+113
| +15% | +$47.2K | 0.19% | 146 |
|
|
2023
Q4 | $311K | Buy |
+765
| New | +$311K | 0.17% | 173 |
|
|
2023
Q3 | – | Sell |
-682
| Closed | -$240K | – | 472 |
|
|
2023
Q2 | $240K | Sell |
682
-282
| -29% | -$99.2K | 0.14% | 247 |
|
|
2023
Q1 | $304K | Buy |
964
+59
| +7% | +$18.6K | 0.18% | 173 |
|
|
2022
Q4 | $261K | Buy |
+905
| New | +$261K | 0.04% | 337 |
|
|
2017
Q3 | – | Sell |
-5,839
| Closed | -$752K | – | 354 |
|
|
2017
Q2 | $752K | Buy |
+5,839
| New | +$752K | 0.23% | 152 |
|